Inflammatory cytokine production pathways

Inflammatory cytokine production pathways are integrated signaling networks that control the expression and secretion of pro-inflammatory mediators such as TNF-alpha, IL-1, and IL-6 (Akira et al., 2006). These pathways are triggered by the activation of pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) in response to pathogen-associated or damage-associated molecular patterns (Liu et al., 2017). Key intracellular signaling cascades, including the NF-kappaB, MAPK, and JAK-STAT pathways, relay these signals to the nucleus to initiate the transcription of inflammatory genes (Dinarello, 2000). Chronic overactivation of these pathways is a central feature of many autoimmune and autoinflammatory diseases, such as rheumatoid arthritis and Crohn's disease (Feldmann et al., 2019). Pharmacological strategies to manage these diseases involve targeting specific nodes within these pathways, including cytokine neutralization with monoclonal antibodies or the use of small molecule inhibitors against signaling enzymes like Janus kinases (O'Shea et al., 2013).

Other names

Pro-inflammatory signaling pathwaysCytokine signaling cascadesInflammatory response pathwaysCytokine production pathways

Inhibition of cytokine signaling through neutralization of ligands, blockade of receptors, or inhibition of intracellular kinases like JAKs.